These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of gap junctional conductance by long-chain acylcarnitines and their preferential accumulation in junctional sarcolemma during hypoxia. Wu J; McHowat J; Saffitz JE; Yamada KA; Corr PB Circ Res; 1993 Apr; 72(4):879-89. PubMed ID: 8443874 [TBL] [Abstract][Full Text] [Related]
5. Delineation of the influence of propionylcarnitine on the accumulation of long-chain acylcarnitines and electrophysiologic derangements evoked by hypoxia in canine myocardium. Yamada KA; Dobmeyer DJ; Kanter EM; Priori SG; Corr PB Cardiovasc Drugs Ther; 1991 Feb; 5 Suppl 1():67-76. PubMed ID: 2031873 [TBL] [Abstract][Full Text] [Related]
6. A fixation procedure suitable for autoradiography of endogenous long-chain acyl carnitine. Knabb MT; Ahumada GG; Sobel BE; Saffitz JE J Histochem Cytochem; 1985 Aug; 33(8):744-8. PubMed ID: 4020097 [TBL] [Abstract][Full Text] [Related]
7. Effects of ciprofibrate and 2-[5-(4-chlorophenyl)pentyl]oxirane-2-carboxylate (POCA) on the distribution of carnitine and CoA and their acyl-esters and on enzyme activities in rats. Relation between hepatic carnitine concentration and carnitine acetyltransferase activity. Bhuiyan AK; Bartlett K; Sherratt HS; Agius L Biochem J; 1988 Jul; 253(2):337-43. PubMed ID: 3178716 [TBL] [Abstract][Full Text] [Related]
8. Cellular uncoupling induced by accumulation of long-chain acylcarnitine during ischemia. Yamada KA; McHowat J; Yan GX; Donahue K; Peirick J; Kléber AG; Corr PB Circ Res; 1994 Jan; 74(1):83-95. PubMed ID: 8261598 [TBL] [Abstract][Full Text] [Related]
9. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. DaTorre SD; Creer MH; Pogwizd SM; Corr PB J Mol Cell Cardiol; 1991 Feb; 23 Suppl 1():11-22. PubMed ID: 2038071 [TBL] [Abstract][Full Text] [Related]
10. Effects of L-carnitine on action potential or canine papillary muscle impaired by long chain acyl carnitine. Hayashi H; Suzuki Y; Masumura Y; Kamikawa T; Kobayashi A; Yamazaki N Jpn Heart J; 1982 Jul; 23(4):623-30. PubMed ID: 7131787 [TBL] [Abstract][Full Text] [Related]
11. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. Corr PB; Creer MH; Yamada KA; Saffitz JE; Sobel BE J Clin Invest; 1989 Mar; 83(3):927-36. PubMed ID: 2921326 [TBL] [Abstract][Full Text] [Related]
12. Reduction of ischemia-induced acyl carnitine accumulation by TDGA and its influence on lactate dehydrogenase release in diabetic rat hearts. Hekimian G; Feuvray D Diabetes; 1986 Aug; 35(8):906-10. PubMed ID: 3732631 [TBL] [Abstract][Full Text] [Related]
13. Lysophospholipids, long chain acylcarnitines and membrane dysfunction in the ischaemic heart. Corr PB; Saffitz JE; Sobel BE Basic Res Cardiol; 1987; 82 Suppl 1():199-208. PubMed ID: 3311006 [TBL] [Abstract][Full Text] [Related]
14. Electrophysiological effects of acetyl glyceryl ether phosphorylcholine on cardiac tissues: comparison with lysophosphatidylcholine and long chain acyl carnitine. Nakaya H; Tohse N Br J Pharmacol; 1986 Dec; 89(4):749-57. PubMed ID: 3814909 [TBL] [Abstract][Full Text] [Related]
15. The effects of 2[5(4-chlorophenyl)pentyl]oxirane-2-carbonyl-Co-A on mitochondrial oxidations. Turnbull DM; Bartlett K; Younan SI; Sherratt HS Biochem Pharmacol; 1984 Feb; 33(3):475-81. PubMed ID: 6704164 [TBL] [Abstract][Full Text] [Related]
16. Pathophysiologic concentrations of lysophosphoglycerides quantified by electron microscopic autoradiography. Saffitz JE; Corr PB; Lee BI; Gross RW; Williamson EK; Sobel BE Lab Invest; 1984 Mar; 50(3):278-86. PubMed ID: 6700193 [TBL] [Abstract][Full Text] [Related]
17. Influence of carnitine acyltransferase inhibitors on the performance and metabolism of rat cardiac muscle. Reinauer H; Adrian M; Rösen P; Schmitz FJ J Clin Chem Clin Biochem; 1990 May; 28(5):335-9. PubMed ID: 2380671 [TBL] [Abstract][Full Text] [Related]
18. Regulation of carbohydrate and fatty acid utilization by L-carnitine during cardiac development and hypoxia. Abdel-aleem S; St Louis J; Hendrickson SC; El-Shewy HM; El-Dawy K; Taylor DA; Lowe JE Mol Cell Biochem; 1998 Mar; 180(1-2):95-103. PubMed ID: 9546635 [TBL] [Abstract][Full Text] [Related]
19. Involvement of long-chain acyl CoA in the antagonistic effects of halothane and L-carnitine on mitochondrial energy-linked processes. Branca D; Toninello A; Scutari G; Florian M; Siliprandi N; Vincenti E; Giron GP Biochem Biophys Res Commun; 1986 Aug; 139(1):303-7. PubMed ID: 3767958 [TBL] [Abstract][Full Text] [Related]
20. Selected metabolic alterations in the ischemic heart and their contributions to arrhythmogenesis. Corr PB; Yamada KA Herz; 1995 Jun; 20(3):156-68. PubMed ID: 7543431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]